Abnormalities in human pluripotent cells due to reprogramming mechanisms

Hong Ma, Robert Morey, Ryan C. O'Neil, Yupeng He, Brittany Daughtry, Matthew D. Schultz, Manoj Hariharan, Joseph R. Nery, Rosa Castanon, Karen Sabatini, Rathi D. Thiagarajan, Masahito Tachibana, Eunju Kang, Rebecca Tippner-Hedges, Riffat Ahmed, Nuria Marti Gutierrez, Crystal Van Dyken, Alim Polat, Atsushi Sugawara, Michelle SparmanSumita Gokhale, Paula Amato, Don P. Wolf, Joseph R. Ecker, Louise C. Laurent, Shoukhrat Mitalipov

Research output: Contribution to journalArticle

191 Citations (Scopus)

Abstract

Human pluripotent stem cells hold potential for regenerative medicine, but available cell types have significant limitations. Although embryonic stemcells (ES cells) frominvitro fertilizedembryos (IVFES cells) represent the 'gold standard', theyare allogeneic to patients. Autologous induced pluripotent stem cells (iPS cells) are prone to epigenetic and transcriptional aberrations. To determine whether such abnormalities are intrinsic to somatic cell reprogramming or secondary to the reprogramming method, genetically matched sets of human IVF ES cells, iPS cells and nuclear transfer ES cells (NT ES cells) derived by somatic cell nuclear transfer (SCNT) were subjected to genome-wide analyses. Both NT ES cells and iPS cells derived from the same somatic cells contained comparable numbers of de novo copy number variations. In contrast, DNA methylation and transcriptome profiles of NT ES cells corresponded closely to those of IVF ES cells, whereas iPS cells differed and retained residual DNA methylation patterns typical of parental somatic cells. Thus, human somatic cells can be faithfully reprogrammed to pluripotency by SCNTand are therefore ideal for cell replacement therapies.

Original languageEnglish (US)
Pages (from-to)177-183
Number of pages7
JournalNature
Volume511
Issue number7508
DOIs
StatePublished - 2014

Fingerprint

Induced Pluripotent Stem Cells
DNA Methylation
Pluripotent Stem Cells
Regenerative Medicine
Cell- and Tissue-Based Therapy
Transcriptome
Epigenomics
Genome

ASJC Scopus subject areas

  • General

Cite this

Ma, H., Morey, R., O'Neil, R. C., He, Y., Daughtry, B., Schultz, M. D., ... Mitalipov, S. (2014). Abnormalities in human pluripotent cells due to reprogramming mechanisms. Nature, 511(7508), 177-183. https://doi.org/10.1038/nature13551

Abnormalities in human pluripotent cells due to reprogramming mechanisms. / Ma, Hong; Morey, Robert; O'Neil, Ryan C.; He, Yupeng; Daughtry, Brittany; Schultz, Matthew D.; Hariharan, Manoj; Nery, Joseph R.; Castanon, Rosa; Sabatini, Karen; Thiagarajan, Rathi D.; Tachibana, Masahito; Kang, Eunju; Tippner-Hedges, Rebecca; Ahmed, Riffat; Gutierrez, Nuria Marti; Van Dyken, Crystal; Polat, Alim; Sugawara, Atsushi; Sparman, Michelle; Gokhale, Sumita; Amato, Paula; Wolf, Don P.; Ecker, Joseph R.; Laurent, Louise C.; Mitalipov, Shoukhrat.

In: Nature, Vol. 511, No. 7508, 2014, p. 177-183.

Research output: Contribution to journalArticle

Ma, H, Morey, R, O'Neil, RC, He, Y, Daughtry, B, Schultz, MD, Hariharan, M, Nery, JR, Castanon, R, Sabatini, K, Thiagarajan, RD, Tachibana, M, Kang, E, Tippner-Hedges, R, Ahmed, R, Gutierrez, NM, Van Dyken, C, Polat, A, Sugawara, A, Sparman, M, Gokhale, S, Amato, P, Wolf, DP, Ecker, JR, Laurent, LC & Mitalipov, S 2014, 'Abnormalities in human pluripotent cells due to reprogramming mechanisms', Nature, vol. 511, no. 7508, pp. 177-183. https://doi.org/10.1038/nature13551
Ma H, Morey R, O'Neil RC, He Y, Daughtry B, Schultz MD et al. Abnormalities in human pluripotent cells due to reprogramming mechanisms. Nature. 2014;511(7508):177-183. https://doi.org/10.1038/nature13551
Ma, Hong ; Morey, Robert ; O'Neil, Ryan C. ; He, Yupeng ; Daughtry, Brittany ; Schultz, Matthew D. ; Hariharan, Manoj ; Nery, Joseph R. ; Castanon, Rosa ; Sabatini, Karen ; Thiagarajan, Rathi D. ; Tachibana, Masahito ; Kang, Eunju ; Tippner-Hedges, Rebecca ; Ahmed, Riffat ; Gutierrez, Nuria Marti ; Van Dyken, Crystal ; Polat, Alim ; Sugawara, Atsushi ; Sparman, Michelle ; Gokhale, Sumita ; Amato, Paula ; Wolf, Don P. ; Ecker, Joseph R. ; Laurent, Louise C. ; Mitalipov, Shoukhrat. / Abnormalities in human pluripotent cells due to reprogramming mechanisms. In: Nature. 2014 ; Vol. 511, No. 7508. pp. 177-183.
@article{005c232045bb4e6ca70eff516d6838ba,
title = "Abnormalities in human pluripotent cells due to reprogramming mechanisms",
abstract = "Human pluripotent stem cells hold potential for regenerative medicine, but available cell types have significant limitations. Although embryonic stemcells (ES cells) frominvitro fertilizedembryos (IVFES cells) represent the 'gold standard', theyare allogeneic to patients. Autologous induced pluripotent stem cells (iPS cells) are prone to epigenetic and transcriptional aberrations. To determine whether such abnormalities are intrinsic to somatic cell reprogramming or secondary to the reprogramming method, genetically matched sets of human IVF ES cells, iPS cells and nuclear transfer ES cells (NT ES cells) derived by somatic cell nuclear transfer (SCNT) were subjected to genome-wide analyses. Both NT ES cells and iPS cells derived from the same somatic cells contained comparable numbers of de novo copy number variations. In contrast, DNA methylation and transcriptome profiles of NT ES cells corresponded closely to those of IVF ES cells, whereas iPS cells differed and retained residual DNA methylation patterns typical of parental somatic cells. Thus, human somatic cells can be faithfully reprogrammed to pluripotency by SCNTand are therefore ideal for cell replacement therapies.",
author = "Hong Ma and Robert Morey and O'Neil, {Ryan C.} and Yupeng He and Brittany Daughtry and Schultz, {Matthew D.} and Manoj Hariharan and Nery, {Joseph R.} and Rosa Castanon and Karen Sabatini and Thiagarajan, {Rathi D.} and Masahito Tachibana and Eunju Kang and Rebecca Tippner-Hedges and Riffat Ahmed and Gutierrez, {Nuria Marti} and {Van Dyken}, Crystal and Alim Polat and Atsushi Sugawara and Michelle Sparman and Sumita Gokhale and Paula Amato and Wolf, {Don P.} and Ecker, {Joseph R.} and Laurent, {Louise C.} and Shoukhrat Mitalipov",
year = "2014",
doi = "10.1038/nature13551",
language = "English (US)",
volume = "511",
pages = "177--183",
journal = "Nature",
issn = "0028-0836",
publisher = "Nature Publishing Group",
number = "7508",

}

TY - JOUR

T1 - Abnormalities in human pluripotent cells due to reprogramming mechanisms

AU - Ma, Hong

AU - Morey, Robert

AU - O'Neil, Ryan C.

AU - He, Yupeng

AU - Daughtry, Brittany

AU - Schultz, Matthew D.

AU - Hariharan, Manoj

AU - Nery, Joseph R.

AU - Castanon, Rosa

AU - Sabatini, Karen

AU - Thiagarajan, Rathi D.

AU - Tachibana, Masahito

AU - Kang, Eunju

AU - Tippner-Hedges, Rebecca

AU - Ahmed, Riffat

AU - Gutierrez, Nuria Marti

AU - Van Dyken, Crystal

AU - Polat, Alim

AU - Sugawara, Atsushi

AU - Sparman, Michelle

AU - Gokhale, Sumita

AU - Amato, Paula

AU - Wolf, Don P.

AU - Ecker, Joseph R.

AU - Laurent, Louise C.

AU - Mitalipov, Shoukhrat

PY - 2014

Y1 - 2014

N2 - Human pluripotent stem cells hold potential for regenerative medicine, but available cell types have significant limitations. Although embryonic stemcells (ES cells) frominvitro fertilizedembryos (IVFES cells) represent the 'gold standard', theyare allogeneic to patients. Autologous induced pluripotent stem cells (iPS cells) are prone to epigenetic and transcriptional aberrations. To determine whether such abnormalities are intrinsic to somatic cell reprogramming or secondary to the reprogramming method, genetically matched sets of human IVF ES cells, iPS cells and nuclear transfer ES cells (NT ES cells) derived by somatic cell nuclear transfer (SCNT) were subjected to genome-wide analyses. Both NT ES cells and iPS cells derived from the same somatic cells contained comparable numbers of de novo copy number variations. In contrast, DNA methylation and transcriptome profiles of NT ES cells corresponded closely to those of IVF ES cells, whereas iPS cells differed and retained residual DNA methylation patterns typical of parental somatic cells. Thus, human somatic cells can be faithfully reprogrammed to pluripotency by SCNTand are therefore ideal for cell replacement therapies.

AB - Human pluripotent stem cells hold potential for regenerative medicine, but available cell types have significant limitations. Although embryonic stemcells (ES cells) frominvitro fertilizedembryos (IVFES cells) represent the 'gold standard', theyare allogeneic to patients. Autologous induced pluripotent stem cells (iPS cells) are prone to epigenetic and transcriptional aberrations. To determine whether such abnormalities are intrinsic to somatic cell reprogramming or secondary to the reprogramming method, genetically matched sets of human IVF ES cells, iPS cells and nuclear transfer ES cells (NT ES cells) derived by somatic cell nuclear transfer (SCNT) were subjected to genome-wide analyses. Both NT ES cells and iPS cells derived from the same somatic cells contained comparable numbers of de novo copy number variations. In contrast, DNA methylation and transcriptome profiles of NT ES cells corresponded closely to those of IVF ES cells, whereas iPS cells differed and retained residual DNA methylation patterns typical of parental somatic cells. Thus, human somatic cells can be faithfully reprogrammed to pluripotency by SCNTand are therefore ideal for cell replacement therapies.

UR - http://www.scopus.com/inward/record.url?scp=84904214305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904214305&partnerID=8YFLogxK

U2 - 10.1038/nature13551

DO - 10.1038/nature13551

M3 - Article

C2 - 25008523

AN - SCOPUS:84904214305

VL - 511

SP - 177

EP - 183

JO - Nature

JF - Nature

SN - 0028-0836

IS - 7508

ER -